See if a non-drug therapy reduces nightmares in adults with narcolepsy

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study examines whether imagery rehearsal therapy, a behavioral treatment, can lessen nightmare frequency in adults with narcolepsy. All participants receive the therapy, with timing staggered across assessments to allow comparison. Romantic partners of participants may enroll to complete assessments but do not receive the therapy. Participants must have narcolepsy with frequent nightmares, be 18 or older, and live in the United States and maintain stable medications. Outcomes are measured across three assessments to track changes over time.

Why it matters

Who can join: the full rules

PARTICIPANTS WITH NARCOLEPSY/NIGHTMARES

Inclusion Criteria:

* Diagnosis of narcolepsy type 1 or narcolepsy type 2
* Nightmare frequency of ≥1 times per week
* Age 18 or older
* Able to speak, read, and write in English
* Live in the United States
* Sleep and psychiatric medications stable for ≥ 1 month and willing to keep medications stable for the duration of the study

Exclusion Criteria:

* Currently engaged in trauma- or sleep-related psychotherapy
* Previous behavioral treatment for nightmares
* Medical, psychiatric, or cognitive condition which would interfere with ability to engage in the treatment
* Untreated moderate-severe sleep apnea

PARTICIPANTS WHO ARE PARTNERS OF SOMEONE WITH NARCOLEPSY

Inclusion Criteria:

* Live with a romantic partner who meets the above criteria and has agreed to participate in the study
* Age 18 or older
* Able to speak, read, and write in English
* Live in the United States

Where it's running

• University of Utah
  Salt Lake City, Utah, United States Recruiting

Study contacts

• Study coordinator: Jennifer Mundt, PhD
• Email: DAWNstudy@utah.edu
• Phone: 801-646-8287

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Behavioral therapy to reduce nightmares in REM sleep behavior disorder

  This trial will test whether a non-medication behavioral therapy delivered by videoconference can reduce frequent nightmares in adults with REM sleep behavior disorder while involving a family member.

  Recruiting University of Utah · Salt Lake City, Utah · NCT06441864

• Temporal interference stimulation for narcolepsy type 1

  A noninvasive brain stimulation test to see if theta-burst temporal interference can help people with narcolepsy type 1.

  Recruiting Xijing Hospital · Xi'an, Shaanxi · NCT07727239

• HBS-301 for Narcolepsy: daily wakefulness and sleepiness improvement in adults

  This Phase 3 study tests HBS-301 vs placebo in adults with narcolepsy to see if it helps with daytime sleepiness, cataplexy, sleepiness, and fatigue.

  Recruiting at 29 sites Phase 3 Harmony Biosciences Management, Inc. · Birmingham, Alabama and 52 other locations · NCT07675135

• Long-term test of TAK-360 in people with narcolepsy or idiopathic hypersomnia

  This study tests TAK-360 over an extended period to see if it is tolerable for people with narcolepsy type 1, narcolepsy type 2, or idiopathic hypersomnia who completed an earlier TAK-360 trial.

  Recruiting at 33 sites Phase 2/3 Takeda · Chula Vista, California and 32 other locations · NCT07646678

• TAK-360 in adults with narcolepsy Type 1 with cataplexy

  This study tests TAK-360 versus placebo in adults with narcolepsy Type 1 to see if it is safe and tolerable.

  Recruiting at 9 sites Phase 2 Takeda · Redwood City, California and 17 other locations · NCT07633301

• Expanded-dosing Xywav vs placebo in narcolepsy and IH

  This study tests whether expanded nightly dosing of Xywav helps adults with narcolepsy or idiopathic hypersomnia, compared with placebo.

  Recruiting at 15 sites Phase 3 Jazz Pharmaceuticals · Birmingham, Alabama and 14 other locations · NCT07625280

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.